Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M363Revenue $M11.3Net Margin (%)-593.0Z-Score7.9
Enterprise Value $M185EPS $-0.4Operating Margin %-591.0F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-593.0Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %-12.8Quick Ratio11.4Cash flow > EarningsY
Price/Sales23.65-y EBITDA Growth Rate %-3.2Current Ratio11.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-35.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M263ROI % (ttm)-67.6Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXJohn Burbank 2013-12-31 Sold Out -0.05%$1.11 - $2
($1.46)
$ 1.38-6%Sold Out0
DVAXJohn Burbank 2013-09-30 Buy $1.06 - $1.43
($1.26)
$ 1.3810%New holding, 63492 sh.63,492
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$3.55 - $5.21
($4.27)
$ 1.38-68%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$3.28 - $4.94
($3.8)
$ 1.38-64%Reduce -62.5%375,000
DVAXGeorge Soros 2011-12-31 Buy 0.14%$1.82 - $3.33
($2.79)
$ 1.38-50%New holding, 1000000 sh.1,000,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$1.84 - $3.16
($2.45)
$ 1.38-44%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy $2.46 - $2.81
($2.63)
$ 1.38-48%New holding, 66100 sh.66,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ORONSKY ARNOLD LDirector 2013-10-30Buy186,047$1.0827.78 view
KISNER DANIEL LDirector 2013-10-30Buy10,000$1.0827.78 view
Phillips Peggy VDirector 2013-10-30Buy93,023$1.0827.78 view
COFFMAN ROBERTChief Scientific Officer & VP 2012-11-06Sell8,000$4.31-67.98 view
KESSEL MARKDirector 2012-10-16Sell6,000,000$4.73-70.82 view
COFFMAN ROBERTChief Scientific Officer & VP 2012-10-05Sell8,000$4.94-72.06 view
Lew JenniferVP, Finance & PAO 2012-09-14Sell18,750$4.53-69.54 view
COFFMAN ROBERTChief Scientific Officer & VP 2012-09-13Sell8,000$4.52-69.47 view
ORONSKY ARNOLD LDirector 2011-11-08Buy160,000$2.5-44.8 view
CANO FRANCISDirector 2011-08-05Buy20,000$2.54-45.67 view

Press Releases about DVAX :

    Quarterly/Annual Reports about DVAX:

    News about DVAX:

    Articles On GuruFocus.com
    Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
    Top Three Largest Insider Buys of the Past Week Nov 05 2013 
    About to submit BLA Mar 11 2012 
    Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
    Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
    Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
    Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 
    Dynavax Technologies Corp. Reports Operating Results (10-Q) Oct 30 2009 
    Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 06 2009 
    Dynavax Announces Second Quarter 2009 Financial Results Aug 04 2009 

    More From Other Websites
    Will Dynavax (DVAX) Continue to Surge Higher? Jun 18 2014
    Dynavax to Present at the William Blair 2014 Growth Stock Conference Jun 09 2014
    Dynavax to Present at the Jefferies Global Healthcare Conference Jun 02 2014
    DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission... May 29 2014
    Dynavax (DVAX) Sees Hammer Chart Pattern: Time to Buy? May 27 2014
    DYNAVAX TECHNOLOGIES CORP Financials May 10 2014
    Dynavax Reports In Line Q1 Results May 06 2014
    DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2014
    DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report May 05 2014
    Dynavax Reports First Quarter 2014 Financial Results May 05 2014
    Five Small Biotech Stocks Analysts Think Will Triple Apr 30 2014
    Ambit Biosciences Slumps: AMBI Falls 7.1% in Session Apr 24 2014
    DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 16 2014
    Dynavax Starts Phase III Study on Heplisav-B Apr 16 2014
    Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM) Apr 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide